πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8507445

Compositions and methods of use of targeting peptides for diagnosis and therapy of human c

The Board of Regents of the University of Texas System Β· Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8486385

Methods for therapy of neurodegenerative disease of the brain

The Regents of the University of California Β· Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8486370

Heterocyclic ligands for integrin imaging and therapy

The Regents of the University of California Β· Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8480995

Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic effic

UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481529

Combination cancer chemotherapy

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8476254

Methods for treating psychosis associated with interferson-Ξ± therapy

Corcept Therapeutics Incorporated Β· Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8475764

Labelled adrenomedullin derivatives and their use for imaging and therapy

INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8470312

Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8470326

Monoclonal antibody therapy for pancreas cancer

PRECISION BIOLOGICS, INC. Β· Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440168

Image-guided therapy of myocardial disease: composition, manufacturing and applications

The Board of Regents of the University of Texas System Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8435575

Use of gingerols for cancer patients suffering from nausea and emesis induced by chemother

Aphios Corporation Β· Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8415384

Reducing myocardial reperfusion injury by the combination therapy of protein kinase A acti

The Board of Regents of the University of Texas System Β· Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8414911

Photochemical therapy to affect mechanical and/or chemical properties of body tissue

The Regents of the University of California Β· Granted Tue Apr 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394377

Methods for treating cancer using combination therapy

The Regents of the University of Colorado Β· Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8394411

Papillomavirus pseudoviruses for detection and therapy of tumors

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8383099

Adoptive cell therapy with young T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8372826

Estriol therapy for multiple sclerosis and other autoimmune diseases

The Regents of the University of California Β· Granted Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8338173

Preparation of antigen-presenting human Ξ³Ξ΄ T cells and use in immunotherapy

University College Cardiff Consultants Limited Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8337830

Yeast-based vaccines as immunotherapy

The Regents of the University of Colorado Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8323906

Compositions, kits, and methods for identification, assessment, prevention and therapy of

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8287857

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative l

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8257918

Intelligent nanomedicine integrating diagnosis and therapy

The Regents of the University of California Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8258116

Combination therapy for the treatment of HCV infection

Vertex Pharmaceuticals Incorporated Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8252267

DKKL-1 splice product modulators for cancer diagnosis and therapy

Sagres Discovery, Inc. Β· Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted